Investing.com -- DexCom , Inc. (NASDAQ: DXCM) saw its shares jump 3.9% after the continuous glucose monitoring (CGM) device maker reported first-quarter revenue that surpassed analyst estimates, ...

DexCom (DXCM) reported $1.04 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 12.5%. EPS of $0.32 for the same period compares to $0.32 a year ago. The ...

Medical device company DexCom (NASDAQ:DXCM) announced in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported first-quarter earnings of $105.4 million. On a per-share basis, the San Diego-based company said it had net income of 27 cents ...

Medical device maker Dexcom beat first-quarter sales estimates helped by strong demand for its continuous glucose monitors (CGMs) used by patients with diabetes.

The United States does not have to return a Maryland man who was accidentally deported to a high-security prison in El Salvador to U.S. soil by midnight, the Supreme Court ruled Monday in an ...

(NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, ...

NEW YORK, April 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM ) breached their ...

Here are four promising growth stocks that can help increase the value of your investment portfolio. The post Looking for ...

Shares of DexCom Inc. DXCM slid 3.59% to $66.11 Monday, on what proved to be an all-around rough trading session for the ...